Inventor

KALISIAK JAROSLAW

US34 patents

⚠️ This page may combine multiple inventors who share the name “KALISIAK JAROSLAW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KALISIAK JAROSLAW

CHEMOCENTRYX INC

Modulators of chemokine receptors

Inhibitors of CXCR2

Processes and intermediates in the preparation of C5aR antagonists

Processes and intermediates in the preparation of C5aR antagonists

Substituted tetrahydropyrans as CCR2 modulators

Inhibitors of CXCR2

Modulators of chemokine receptors

Processes and intermediates in the preparation of C5aR antagonists

Substituted tetrahydropyrans as CCR2 modulators

Inhibitors of CXCR2

Modulators of chemokine receptors

CCR6 compounds

Substituted tetrahydropyrans as CCR2 modulators

Inhibitors of CXCR2

Processes and intermediates in the preparation of C5aR antagonists

Modulators of chemokine receptors

CCR6 compounds

CCR6 compounds

ARCUS BIOSCIENCES INC

Modulators of 5′-nucleotidase, ecto and the use thereof

Modulators of 5′-nucleotidase, ecto and the use thereof

Modulators of 5′-nucleotidase, ecto and the use thereof

Modulators of 5′-nucleotidase, ecto and the use thereof

Inhibitors of adenosine 5′-nucleotidase

Process for preparing tetralin compounds

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

Inhibitors of adenosine 5′-nucleotidase

Inhibitors of CD73-mediated immunosuppression

Modulators of 5′-nucleotidase, ecto and the use thereof

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Parenterally administered immune enhancing drugs

Inhibitors of ARG1 and/or ARG2

Arginase inhibitors

HUMAN BIOMOLECULAR RES FOUNDATION

Blood brain barrier-penetrating oximes for cholinesterase reactivation